Last updated on June 2020

Safety Tolerability and Efficacy of Cilofexor in Non-Cirrhotic Adults With Primary Sclerosing Cholangitis

Brief description of study

The primary objective of this study is to evaluate whether cilofexor reduces the risk of fibrosis progression among non-cirrhotic adults with primary sclerosing cholangitis (PSC).

Clinical Study Identifier: NCT03890120

Find a site near you

Start Over

Austin Health

Heidelberg, Australia
  Connect »

The Royal Melbourne Hospital

Parkville, Australia
  Connect »

The Alfred Hospital

Melbourne, Australia
  Connect »